What they were paid
KalVista Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $50,000 | $0 | $83,206 | $0 | $133,206 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KalVista Pharmaceuticals, Inc. DEF 14A filed August 21, 2025, accession 0001193125-25-185353, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024KalVista Pharmaceuticals pays directors a $42,500 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Compensation
The rest of the KalVista Pharmaceuticals board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Benjamin L. Palleiko | Director | $0 |
| Brian J. G. Pereira | Independent Director | $170,706 |
| Edward W. Unkart | Independent Director | $145,706 |
| Laurence Reid | Independent Director | $142,500 |
| Nancy Stuart | Independent Director | $145,706 |
| Patrick Treanor | Independent Director | $137,547 |
The full KalVista Pharmaceuticals compensation record
free company briefThis page is one director within KalVista Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat